Insider Cluster (2 insiders) ·Filed Sep 3, 2026

TARS

Tarsus Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed28d 10h ago
Insider cluster: 2 insiders, $928K total
Actionable Insight • Neutral

Insider selling is minimal relative to market cap and likely reflects routine portfolio diversification or tax planning. No bearish read-through. Monitor upcoming earnings or pipeline catalysts for real signals.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d ⚠ clustered
TARS ▼ -4.68% at T+5d
NEUTRAL call ✗ call lost -4.68% · α vs SPY -3.53% · entry $83.21 → $79.31
Next anchor: T+20d due yesterday
Latest observation: T+17 -13.97% FF3 residual α
Entry anchored
Sep 2, 06:16 PM ET
via 1-min bar
T+1d
+9.10%
call +9.10% · α +9.49%
$90.78
settled 29d ago
T+5d
-4.68%
call -4.68% · α -3.53%
$79.31
settled 22d ago
T+20d
—
call — · α —
—
due yesterday
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

CEO Bobak Azamian and CMO Elizabeth Yeu sold a combined $928K in TARS shares over two days. The total represents just 0.026% of the company's $3.6B market cap — a trivial amount that is routine and non-informative. No bearish signal is warranted from this cluster.

Key Financial Metrics

Direction
selling
Total Value
$928.0K
Insiders
2

Key Facts

  • CEO Bobak Azamian sold 10,000 shares at $80.06 for $801K on 2026-09-02.
  • CMO Elizabeth Yeu sold 1,590 shares at $80.00 for $127K on 2026-09-02.
  • Total cluster value of $928K is only 0.026% of TARS's $3.6B market cap.
  • Insider sells are weak predictors per academic literature, especially at this size.

Financial Impact

Negligible — $928K is 0.026% of market cap, well below the 0.1% materiality threshold.

Risk Factors

  • No material risk from this filing; the selling is too small to indicate insider concern.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TARS-1788506906577
13 reports for TARS
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +27.36%Aug 6, 2026
Filters
Rows
Reports for TARS — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$82.77 $77.64▼ −6.20%▼ −5.54%$73.61 (−11.06%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$83.21 $79.31▼ −4.68%▼ −3.53%$73.61 (−11.53%)
Sep 2, 2026
29d ago
144
BEARISH ★ 4/10
$82.76 $81.12▲ +1.98%▲ +1.02%$73.61 (+11.05%)
Sep 1, 2026
4w ago
144
BEARISH ★ 5/10
$82.76 $81.12▲ +1.98%▲ +1.02%$73.61 (+11.05%)
Aug 19, 2026
6w ago
144
NEUTRAL ★ 3/10
$73.44 $70.65▼ −3.80%▼ −3.41%$73.61 (+0.24%)
Aug 6, 2026
8w ago
8-K
MIXED ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
8-K
MIXED ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
Press Release
BULLISH ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Showing 10 of 13

US Market Status

Market Open — Closes in 2h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 4, 2026